Log in

Relevant bibliographies by topics / 920102 Cancer and Related Disorders / Journal articles

Journal articles on the topic '920102 Cancer and Related Disorders'

To see the other types of publications on this topic, follow the link: 920102 Cancer and Related Disorders.

Author: Grafiati

Published: 10 December 2022

Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic '920102 Cancer and Related Disorders.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Roscoe, Joseph A., Maralyn E. Kaufman, Sara E. Matteson‐Rusby, Oxana G. Palesh, Julie L. Ryan, Sadhna Kohli, Michael L. Perlis, and Gary R. Morrow. "Cancer‐Related Fatigue and Sleep Disorders." Oncologist 12, S1 (May 2007): 35–42. http://dx.doi.org/10.1634/theoncologist.12-s1-35.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Katzin, William E. "Cancer (Multiple Myeloma and Related Disorders)." Analytical Chemistry 65, no. 12 (June 15, 1993): 382–87. http://dx.doi.org/10.1021/ac00060a603.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Balachandran, Diwakar D., Saadia Faiz, Lara Bashoura, and Ellen Manzullo. "Cancer-Related Fatigue and Sleep Disorders." Sleep Medicine Clinics 8, no. 2 (June 2013): 229–34. http://dx.doi.org/10.1016/j.jsmc.2013.02.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Balachandran, Diwakar D., Lara Bashoura, and Saadia A. Faiz. "Sleep-Related Breathing Disorders and Cancer." Current Pulmonology Reports 6, no. 2 (May 17, 2017): 90–101. http://dx.doi.org/10.1007/s13665-017-0182-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Scalapino, Kenneth J., and Charles R. Thomas. "Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders." Rheumatic Disease Clinics of North America 37, no. 4 (November 2011): ix—x. http://dx.doi.org/10.1016/j.rdc.2011.09.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Shimizu, Ritsuko, and Masayuki Yamamoto. "GATA-related hematologic disorders." Experimental Hematology 44, no. 8 (August 2016): 696–705. http://dx.doi.org/10.1016/j.exphem.2016.05.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Jiang, Yan, Dan Liang, Yadi He, Jing Wang, Guixing Xu, and Jun Wang. "Acupuncture and moxibustion for cancer-related psychological disorders." Medicine 101, no. 10 (March 11, 2022): e28860. http://dx.doi.org/10.1097/md.0000000000028860.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Strasser, Florian. "Eating-related disorders in patients with advanced cancer." Supportive Care in Cancer 11, no. 1 (January 2003): 11–20. http://dx.doi.org/10.1007/s00520-002-0391-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Balachandran, Diwakar D., Lara Bashoura, Saadia Faiz, Brenda Aaron-Remmert, Micheal Kallen, Rosalie Valdres, Tony Lam, Carmen Escalante, and Ellen Manzullo. "SLEEP DISORDERS IN PATIENTS WITH CANCER-RELATED FATIGUE." Chest 136, no. 4 (October 2009): 33S. http://dx.doi.org/10.1378/chest.136.4_meetingabstracts.33s-g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Schrag, Nicole M., Robert E. McKeown, Kirby L. Jackson, Steven P. Cuffe, and Ronnie W. Neuberg. "Stress-related mental disorders in childhood cancer survivors." Pediatric Blood & Cancer 50, no. 1 (January 2008): 98–103. http://dx.doi.org/10.1002/pbc.21285.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Simonsson-Lindemalm, C. "Cutaneous lymphomas, pseudolymphomas and related disorders." Medical Oncology and Tumor Pharmacotherapy 2, no. 2 (June 1985): 115. http://dx.doi.org/10.1007/bf02934858.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Halliday, Dorothy, Allyson Parry, and D. Gareth Evans. "Neurofibromatosis type 2 and related disorders." Current Opinion in Oncology 31, no. 6 (November 2019): 562–67. http://dx.doi.org/10.1097/cco.0000000000000579.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Wagner-Johnston, Nina D., and Richard F. Ambinder. "Epstein-Barr virus-related lymphoproliferative disorders." Current Hematologic Malignancy Reports 2, no. 4 (October 2007): 249–54. http://dx.doi.org/10.1007/s11899-007-0034-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Caruso, Rosangela, Anna Clara Morelli, Mara Giulia Nanni, Bruno Biancosino, and Luigi Grassi. "Psychiatric Disorders Related to Cancer: Prevalence, Etiology, and Recognition." Neuropathological Diseases 1, no. 1 (2012): 7–39. http://dx.doi.org/10.1615/neuropatholdiseases.v1.i1.20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Schrag, N., R. McKeown, S. Cuffe, K. Jackson, and R. Neuberg. "485: Stress-Related Mental Disorders in Childhood Cancer Survivors." American Journal of Epidemiology 161, Supplement_1 (June 2005): S122. http://dx.doi.org/10.1093/aje/161.supplement_1.s122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Batra, Akshit, and Sujata Yerawadekar. "Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review." Journal of Contemporary Dental Practice 17, no. 6 (2016): 504–10. http://dx.doi.org/10.5005/jp-journals-10024-1880.

Full text

Abstract:

ABSTRACT Oral squamous cell carcinoma is the most common malignancy of the oral cavity, which is usually preceded by a myriad of oral potentially malignant disorders (OPMDs). In the classification of OPMDs, inherited cancer syndromes (ICSs) were proposed as one of the categories. Inherited cancer syndromes are genetic disorders in which inherited genetic mutation in one or more genes predispose the affected individuals to the development of cancer and may also cause its early onset. Many of these syndromes are caused by mutations in tumor suppressor genes, oncogenes, and genes involved in angiogenesis. General dental practitioners frequently come across OPMDs in their day-to-day practice. It becomes of paramount importance to have knowledge about these rare but prognostically important OPMDs. With this view in mind, in this article, efforts have been made to comprehensively discuss about various ICSs that have higher potential of transformation into oral cancer. The ICSs discussed in this article are xeroderma pigmentosum (XP), ataxia telangiectasia (AT), Bloom syndrome (BS), Fanconi's anemia (FA), and Li–Fraumeni syndrome (LFS), with special emphasis on signs, symptoms, and genetic considerations. How to cite this article Sarode GS, Batra A, Sarode SC, Yerawadekar S, Patil S. Oral Cancer-related Inherited Cancer Syndromes: A Comprehensive Review. J Contemp Dent Pract 2016;17(6):504-510.

APA, Harvard, Vancouver, ISO, and other styles

17

Smyth, Dion. "Study of alcohol-related disorders in patients with advanced cancer." Cancer Nursing Practice 11, no. 8 (October 11, 2012): 11. http://dx.doi.org/10.7748/cnp.11.8.11.s8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Zee, Phyllis C., and Sonia Ancoli-Israel. "Does Effective Management of Sleep Disorders Reduce Cancer-Related Fatigue?" Drugs 69, Supplement 2 (December 2009): 29–41. http://dx.doi.org/10.2165/11531140-000000000-00000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ahmad, Sarfraz, and Asif Ahsan Ansari. "Therapeutic Roles of Heparin Anticoagulants in Cancer and Related Disorders." Medicinal Chemistry 7, no. 5 (September 1, 2011): 504–17. http://dx.doi.org/10.2174/157340611796799104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Cleaver, James E. "Cancer in xeroderma pigmentosum and related disorders of DNA repair." Nature Reviews Cancer 5, no. 7 (July 2005): 564–73. http://dx.doi.org/10.1038/nrc1652.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Cesana, Clara, Luciana Barbarano, Sara Miqueleiz, Camilla Lucchesini, Francesca Ricci, Marzia Varettoni, Davide Filippini, Mario Lazzarino, and Enrica Morra. "Clinical Characteristics and Outcome of Immunoglobulin M–Related Disorders." Clinical Lymphoma 5, no. 4 (March 2005): 261–64. http://dx.doi.org/10.3816/clm.2005.n.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Tokuhira, Michihide, Shuntaro Saito, Katsuya Suzuki, Morihiro Higashi, Shuju Momose, Takayuki Shimizu, Takehiko Mori, et al. "Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders." Leukemia & Lymphoma 60, no. 10 (April 5, 2019): 2508–15. http://dx.doi.org/10.1080/10428194.2019.1585841.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Oosterveld, M., W. J. Lesterhuis, M. MacKenzie, and J. H. J. M. van Krieken. "EBV-related lymphoproliferative disorders in immunocompetent patients." Leukemia 17, no. 12 (October 2, 2003): 2537–38. http://dx.doi.org/10.1038/sj.leu.2403155.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Rose, Michal G., and Nancy Berliner. "T‐Cell Large Granular Lymphocyte Leukemia and Related Disorders." Oncologist 9, no. 3 (June 2004): 247–58. http://dx.doi.org/10.1634/theoncologist.9-3-247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Golchin, Ava, and George Anthony Dawson. "Online survey of young adult cancer survivors and illness-related stressors." Journal of Clinical Oncology 35, no. 5_suppl (February 10, 2017): 33. http://dx.doi.org/10.1200/jco.2017.35.5_suppl.33.

Full text

Abstract:

33 Background: Post-traumatic stress disorder (PTSD) in cancer patients and those with life threatening illnesses has been officially recognized in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition: DSM-4, since 1994. However, the updated 2013 DSM-V has redefined the idea of trauma and stress-related disorders resulting from life threatening illness as an amalgam of anxiety and adjustment disorders which must meet heightened criteria to be diagnosed as cancer-related PTSD (ca-PTSD) (1). Methods: In this pilot survey of Millennials and Generation X cancer survivors, ages 18-35 and 35-50 respectively, we queried based on DSM-V guidelines for basic demographics, illness-related stressors, as well as knowledge of ca-PTSD. We sent an electronic survey to 20 members of a social support group in May 2016. Results: Of the 13 survey respondents, 9 were female and 4 were male. Half of the respondents were from the Generation X and Millennial groups. None were military veterans. 6 were single, 4 were married, and 3 were in stable long term relations. 11 of 13 had a college degree or greater, and all but one had their cancer diagnosed after 2010. Respondents rated illness stressors as: 92% Possible illness progression; 77% Romance and/or reproductive; 77% Job-related; 77% Family dynamics and insecurities; 69% Social interaction insecurities; 69% Physician or Care-provider interactions and insecurities. All were aware of PTSD in general but only 4 reported discussion with a care provider. None recalled being screened for PTSD. Eight were unsure if more emphasis should be placed on ca-PTSD. Conclusions: This cohort further validates the new DSM-V inclusion of illness-adjustment and resultant anxiety to diagnose cancer related stress disorders, narrowing the scope of ca-PTSD diagnosis.With this survey we underline the importance of identifying illness-related stressors utilizing psychological distress monitoring, educating patients on symptoms and prevalence of cancer related stress disorders, and communication with the patient concerning cancer-related stress disorders and ca-PTSD diagnosis.

APA, Harvard, Vancouver, ISO, and other styles

26

Berlin, K., Chister Edling, Bodil Persson, G. Ahlborg, Lena Hillert, Benkt Högstedt, Ingvar Lundberg, B.-G. Svensson, G. Thiringer, and Palle Ørbæk. "Cancer incidence and mortality of patients with suspected solvent related disorders." Scandinavian Journal of Work, Environment & Health 21, no. 5 (October 1995): 362–67. http://dx.doi.org/10.5271/sjweh.50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Ariazi, Eric, and V. Jordan. "Estrogen-Related Receptors as Emerging Targets in Cancer and Metabolic Disorders." Current Topics in Medicinal Chemistry 6, no. 3 (February 1, 2006): 203–15. http://dx.doi.org/10.2174/1568026610606030203.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Shirakami, Yohei, Masaya Ohnishi, Hiroyasu Sakai, Takuji Tanaka, and Masahito Shimizu. "Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation." International Journal of Molecular Sciences 18, no. 5 (April 26, 2017): 908. http://dx.doi.org/10.3390/ijms18050908.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

De Petrocellis, Luciano, Dominique Melck, Tiziana Bisogno, and Vincenzo Di Marzo. "Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders." Chemistry and Physics of Lipids 108, no. 1-2 (November 2000): 191–209. http://dx.doi.org/10.1016/s0009-3084(00)00196-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Needleman, Samuel W. "RasProtooncogene Activation in Acute Myeloid Leukemia and Related Disorders." Leukemia & Lymphoma 5, no. 2-3 (January 1991): 85–91. http://dx.doi.org/10.3109/10428199109068110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Brzecka, Anna, Karolina Sarul, Tomasz Dyła, Marco Avila-Rodriguez, Ricardo Cabezas-Perez, Vladimir N. Chubarev, Nina N. Minyaeva, et al. "The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer." Current Genomics 21, no. 6 (September 16, 2020): 444–53. http://dx.doi.org/10.2174/1389202921999200403151720.

Full text

Abstract:

Background: Sleep disorders have emerged as potential cancer risk factors. Objective: This review discusses the relationships between sleep, obesity, and breathing disorders with concomitant risks of developing cancer. Results: Sleep disorders result in abnormal expression of clock genes, decreased immunity, and melatonin release disruption. Therefore, these disorders may contribute to cancer development. Moreover, in sleep breathing disorder, which is frequently experienced by obese persons, the sufferer experiences intermittent hypoxia that may stimulate cancer cell proliferation. Discussion: During short- or long- duration sleep, sleep-wake rhythm disruption may occur. Insomnia and obstructive sleep apnea increase cancer risks. In short sleepers, an increased risk of stomach cancer, esophageal squamous cell cancer, and breast cancer was observed. Among long sleepers (>9 hours), the risk of some hematologic malignancies is elevated. Conclusion: Several factors including insomnia, circadian disruption, obesity, and intermittent hypoxia in obstructive sleep apnea are contributing risk factors for increased risk of several types of cancers. However, further studies are needed to determine the more significant of these risk factors and their interactions.

APA, Harvard, Vancouver, ISO, and other styles

32

Thapa, S. "Accuracy of distress thermometer to measure cancer-related mood disorders in Chinese patients with cancer." Annals of Oncology 30 (October 2019): v736. http://dx.doi.org/10.1093/annonc/mdz265.056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Ledbetter, David. "Precision Medicine for Autism and Related Developmental Brain Disorders." Cancer Genetics 209, no. 5 (May 2016): 239. http://dx.doi.org/10.1016/j.cancergen.2016.05.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Joly, Florence, Marie Lange, Melanie Dos Santos, Ines Vaz-Luis, and Antonio Di Meglio. "Long-Term Fatigue and Cognitive Disorders in Breast Cancer Survivors." Cancers 11, no. 12 (November 28, 2019): 1896. http://dx.doi.org/10.3390/cancers11121896.

Full text

Abstract:

Survivors of early-stage breast cancer may report treatment-related side effects that persist for several years after the end of primary treatment. Among these, fatigue and cognitive disorders are frequent complaints and can negatively impact quality of life. Cancer-related fatigue is a very prevalent and distressing long-term side effect among breast cancer survivors that typically improves after completion of treatment, although many patients report severe fatigue several years post-treatment. Cognitive disorders are also common among survivors of breast cancer, especially if treated with chemotherapy. These symptoms are usually mild-to-moderate and often transient. Cognitive recovery is frequently observed within months or a few years after completion of chemotherapy or endocrine therapy. However, some breast cancer survivors may have persistent cognitive difficulties. Several types of interventions have proved to be beneficial in reducing cancer-related fatigue and cognitive difficulties. Most of these interventions for cancer-related fatigue are thought to be effective by reducing inflammation or disrupting pro-inflammatory circuits. Further studies are needed on cognitive management that has showed promising results. This narrative review summarizes the state of the art regarding long-term fatigue and cognitive disorders in patients with early breast cancer, describing prevalence, impact, pathophysiology, and risk factors, and focusing on available interventions.

APA, Harvard, Vancouver, ISO, and other styles

35

Deligiorgi, Maria V., Sofia Sagredou, Lampros Vakkas, and Dimitrios T. Trafalis. "The Continuum of Thyroid Disorders Related to Immune Checkpoint Inhibitors: Still Many Pending Queries." Cancers 13, no. 21 (October 21, 2021): 5277. http://dx.doi.org/10.3390/cancers13215277.

Full text

Abstract:

Background: Until more data are available to shed light on the thyroid disorders related to immune checkpoint inhibitors (ICPi) implemented for the treatment of hematological malignancies, the decision-making is guided by pertinent data derived mostly from solid tumors. Methods: The present review provides a comprehensive and updated overview of the thyroid disorders related to ICPi, namely to inhibitors of cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death (PD) 1 (PD-1), and the ligand of the latter (PD-L1). Results: With the increasing recognition of ir thyroid disorders, many outstanding issues have emerged. Ir thyroid disorders are reminiscent of, but not identical to, thyroid autoimmunity. Interclass and intraclass ICPi differences regarding thyroid immunotoxicity await interpretation. The available data concerning the predictive value of thyroid autoantibodies for the development of ir thyroid disorders are inconclusive. Mounting data indicate an association of ir thyroid disorders with ICPi efficacy, but a causative link is still lacking. The path forward is a tailored approach, entailing: (i) the validation of tumor-specific, patient-specific, and ICPi-specific predictive factors; (ii) appropriate patient selection; (iii) the uncoupling of antitumor immunity from immunotoxicity; (iv) a multidisciplinary initiative; and (v) global registry strategies. Conclusions: Untangling and harnessing the interrelationship of immuno-oncology with endocrinology underlying the ir thyroid disorders will yield the optimal patient care.

APA, Harvard, Vancouver, ISO, and other styles

36

Kaplan, Henry G., Gregory S. Calip, and Judith A. Malmgren. "Maximizing Breast Cancer Therapy with Awareness of Potential Treatment‐Related Blood Disorders." Oncologist 25, no. 5 (February 19, 2020): 391–97. http://dx.doi.org/10.1634/theoncologist.2019-0099.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Li, Bin, Kuokuo Li, Di Tian, Qiao Zhou, Yali Xie, Zhenghuan Fang, Xiaomeng Wang, et al. "De novo mutation of cancer-related genes associates with particular neurodevelopmental disorders." Journal of Molecular Medicine 98, no. 12 (October 12, 2020): 1701–12. http://dx.doi.org/10.1007/s00109-020-01991-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Strik, Herwig, Werner Cassel, Michael Teepker, Thomas Schulte, Jorge Riera-Knorrenschild, Ulrich Koehler, and Ulf Seifart. "Why Do Our Cancer Patients Sleep So Badly? Sleep Disorders in Cancer Patients: A Frequent Symptom with Multiple Causes." Oncology Research and Treatment 44, no. 9 (2021): 469–75. http://dx.doi.org/10.1159/000518108.

Full text

Abstract:

<b><i>Introduction:</i></b> On the one hand, sleep disorders in cancer patients are reported in 30–50% of cancer patients. On the other hand, specific causes for these sleep disorders are little known. This study was done to evaluate factors which may affect sleep of cancer patients. To our knowledge, this is the first study which includes return to work as one factor of sleep disturbance. <b><i>Methods:</i></b> 107 patients with various types of cancer treated in 2 hospitals were interviewed with a battery of questionnaires after having given informed consent. The questionnaires intended to detect abnormalities of sleep and related pain, breathing disorders, restless legs syndrome, depression, rumination, medication, and psychosocial distress. The study was approved by the ethics committee of the University of Marburg. <b><i>Results:</i></b> The analysis of the 6 sleep-related questionnaires indicated a sleep disorder of any kind in 68% of all patients. Insomnia symptoms were present in 48 patients (44.9%). Pain, depression, anxiety, and worries about the workplace were significantly related to sleep disorders. <b><i>Conclusion:</i></b> Sleep disorders are common in cancer patients. The causes are manifold and should be considered by caregivers during diagnosis, therapy, and aftercare of cancer patients. Tumour patients should actively be asked about sleep disorders. If these are present, they should be addressed, and as they have a large impact on quality of life, treatment options should be offered in cooperation with sleep specialists.

APA, Harvard, Vancouver, ISO, and other styles

39

Shekhar, Skand, Jorge A. Irizarry-Caro, Ninet Sinaii, William A. Gahl, Juvianee I. Estrada-Veras, Rahul H. Dave, Bernadette R. Gochuico, et al. "Pituitary Imaging Abnormalities and Related Endocrine Disorders in Erdheim–Chester Disease." Cancers 13, no. 16 (August 17, 2021): 4126. http://dx.doi.org/10.3390/cancers13164126.

Full text

Abstract:

Purpose: We examined abnormal pituitary imaging (API) and associated endocrine dysfunction in subjects with ECD. Methods: A cross-sectional descriptive examination of a natural history cohort study diagnosed with ECD was conducted at a clinical research center. Subjects underwent baseline endocrine tests of anterior and posterior pituitary function and dedicated pituitary gland MRI scans. We determined the frequency of various pituitary imaging abnormalities in ECD and assessed its relationships with age, sex, body mass index (BMI), BRAF V600E status, high sensitivity C-reactive protein (hsCRP), erythrocyte sedimentation rate (ESR), pituitary hormone deficits and number, diabetes insipidus (DI), and panhypopituitarism. Results: Our cohort included 61 subjects with ECD [age (SD): 54.3 (10.9) y, 46 males/15 females]. API was present in 47.5% (29/61) of ECD subjects. Loss of the posterior pituitary bright spot (36.1%) followed by thickened pituitary stalk (24.6%), abnormal enhancement (18.0%), and pituitary atrophy (14.8%) were the most common abnormalities. DI and panhypopituitarism were more frequent in subjects with API without differences in age, sex distribution, hsCRP, ESR, and BRAF V600E status compared to normal pituitary imaging. Conclusions: We noted a high burden of API and endocrinopathies in ECD. API was highly associated with the presence of panhypopituitarism and DI. Therefore, a thorough assessment of hypothalamic–pituitary integrity should be considered in subjects with ECD.

APA, Harvard, Vancouver, ISO, and other styles

40

Simonelli, C., R. Tedeschi, A. Gloghini, M. T. Bortolin, R. Talamini, R. Cinelli, E. Vaccher, P. de Paoli, A. Carbone, and U. Tirelli. "HHV-8-related lymphoproliferative disorders during HIV infection: A monoinstitutional experience." Journal of Clinical Oncology 23, no. 16_suppl (June 2005): 6707. http://dx.doi.org/10.1200/jco.2005.23.16_suppl.6707.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Raymond, Eric, Vivianne Tricottet, Didier Samuel, Michel Reynès, Henri Bismuth, and Jean-Louis Misset. "Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation." Cancer 76, no. 8 (October 15, 1995): 1344–51. http://dx.doi.org/10.1002/1097-0142(19951015)76:8<1344::aid-cncr2820760808>3.0.co;2-k.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Rodriguez, Francisco D., and Rafael Coveñas. "Biochemical Mechanisms Associating Alcohol Use Disorders with Cancers." Cancers 13, no. 14 (July 15, 2021): 3548. http://dx.doi.org/10.3390/cancers13143548.

Full text

Abstract:

The World Health Organization identifies alcohol as a cause of several neoplasias of the oropharynx cavity, esophagus, gastrointestinal tract, larynx, liver, or female breast. We review ethanol’s nonoxidative and oxidative metabolism and one-carbon metabolism that encompasses both redox and transfer reactions that influence crucial cell proliferation machinery. Ethanol favors the uncontrolled production and action of free radicals, which interfere with the maintenance of essential cellular functions. We focus on the generation of protein, DNA, and lipid adducts that interfere with the cellular processes related to growth and differentiation. Ethanol’s effects on stem cells, which are responsible for building and repairing tissues, are reviewed. Cancer stem cells (CSCs) of different origins suffer disturbances related to the expression of cell surface markers, enzymes, and transcription factors after ethanol exposure with the consequent dysregulation of mechanisms related to cancer metastasis or resistance to treatments. Our analysis aims to underline and discuss potential targets that show more sensitivity to ethanol’s action and identify specific metabolic routes and metabolic realms that may be corrected to recover metabolic homeostasis after pharmacological intervention. Specifically, research should pay attention to re-establishing metabolic fluxes by fine-tuning the functioning of specific pathways related to one-carbon metabolism and antioxidant processes.

APA, Harvard, Vancouver, ISO, and other styles

43

Nikolskaya, K. A., T. N. Kuzmina, Ye A. Dubtsova, M. A. Kiryukova, K. K. Noskova, Ye V. Bistrovskaya, V. V. Shchadrova, P. S. Feoktistova, D. S. Bordin, and I. Ye Khatkov. "Correction of Metabolic Disorders in Patients with Pancreatic Cancer." Effective Pharmacotherapy 16, no. 24 (August 31, 2020): 84–90. http://dx.doi.org/10.33978/2307-3586-2020-16-24-84-90.

Full text

Abstract:

Presented the case of complex examination of a patient with pancreatic cancer using a bioimpedance method for assessing the nutritional status before and after surgical treatment. Provided the literature data related to this problem. The presented clinical case demonstrates the features of correction of the nutritional status of a patient with conditionally resectable pancreatic cancer in conditions of cholestasis, severe external pancreatic insufficiency and pancreatogenic diabetes mellitus on the background of constitutional obesity

APA, Harvard, Vancouver, ISO, and other styles

44

Büttner-Teleagă, Antje, Youn-Tae Kim, Tiziana Osel, and Kneginja Richter. "Sleep Disorders in Cancer—A Systematic Review." International Journal of Environmental Research and Public Health 18, no. 21 (November 7, 2021): 11696. http://dx.doi.org/10.3390/ijerph182111696.

Full text

Abstract:

Introduction: Sleep disorders, especially insomnia, are very common in different kinds of cancers, but their prevalence and incidence are not well-known. Disturbed sleep in cancer is caused by different reasons and usually appears as a comorbid disorder to different somatic and psychiatric diagnoses, psychological disturbances and treatment methods. There can be many different predictors for sleep disturbances in these vulnerable groups, such as pre-existing sleep disorders, caused by the mental status in cancer or as side effect of the cancer treatment. Methods: A systematic literature review of 8073 studies was conducted on the topic of sleep and sleep disorders in cancer patients. The articles were identified though PubMed, PsycInfo and Web of Knowledge, and a total number of 89 publications were qualified for analysis. Results: The identified eighty-nine studies were analyzed on the topic of sleep and sleep disorders in cancer, twenty-six studies on sleep and fatigue in cancer and sixty-one studies on the topic of sleep disorders in cancer. The prevalence of sleep disturbences and/or sleep disorders in cancer was up to 95%. Discussion: Sleep disturbances and sleep disorders (such as insomnia, OSAS, narcolepsy and RLS; REM-SBD) in cancer patients can be associated with different conditions. Side effects of cancer treatment and cancer-related psychological dysfunctions can be instigated by sleep disturbances and sleep disorders in these patients, especially insomnia and OSAS are common. An evidence-based treatment is necessary for concomitant mental and/or physical states.

APA, Harvard, Vancouver, ISO, and other styles

45

Hung, Yen-Ni, Shu-Yu Yang, Ming-Chyi Huang, For-Wey Lung, Shih-Ku Lin, Kuan-Yu Chen, Chian-Jue Kuo, and Ying-Yeh Chen. "Cancer incidence in people with affective disorder: nationwide cohort study in Taiwan, 1997–2010." British Journal of Psychiatry 205, no. 3 (September 2014): 183–88. http://dx.doi.org/10.1192/bjp.bp.114.144741.

Full text

Abstract:

BackgroundCancer is a serious public health problem worldwide, and its relationship with affective disorders is not clear.AimsTo investigate alcohol- and tobacco-related cancer risk among patients with affective disorders in a large Taiwanese cohort.MethodRecords of newly admitted patients with affective disorders from January 1997 through December 2002 were retrieved from the Psychiatric Inpatient Medical Claims database in Taiwan. Cancers were stratified by site and grouped into tobacco- or alcohol-related cancers. Standardised incidence ratios (SIRs) were calculated to compare the risk of cancer between those with affective disorders and the general population.ResultsSome 10 207 patients with bipolar disorder and 9826 with major depression were included. The risk of cancer was higher in patients with major depression (SIR = 2.01, 95% CI 1.85–2.19) than in those with bipolar disorder (SIR 1.39, 95% CI 1.26–1.53). The elevated cancer risk among individuals ever admitted to hospital for affective disorders was more pronounced in tobacco- and/or alcohol-related cancers.ConclusionsElevated cancer risk was found in patients who had received in-patient care for affective disorders. They require holistic approaches to lifestyle behaviours and associated cancer risks.

APA, Harvard, Vancouver, ISO, and other styles

46

Woodruff, Tracey J., Daniel A. Axelrad, Amy D. Kyle, Onyemaechi Nweke, Gregory G. Miller, and Bradford J. Hurley. "Trends in Environmentally Related Childhood Illnesses." Pediatrics 113, Supplement_3 (April 1, 2004): 1133–40. http://dx.doi.org/10.1542/peds.113.s3.1133.

Full text

Abstract:

Tracking incidence or prevalence of diseases and using that information to target interventions is a well-established strategy for improving public health. The need to track environmentally mediated chronic diseases is increasingly recognized. Trends in childhood illnesses are 1 element of a framework for children’s environmental health indicators, which also includes trends in contaminants in the environment and in concentrations of contaminants in bodies of children and their mothers. This article presents data on 3 groups of important childhood diseases or disorders that seem to be caused or exacerbated, at least in part, by exposure to environmental agents and for which nationally representative data are available. They are asthma, childhood cancers, and neurodevelopmental disorders. Data were used from the National Health Interview Survey for asthma and neurodevelopmental disorders; the Surveillance, Epidemiology, and End Results Program for childhood cancer incidence; and the National Vital Statistics System for childhood cancer mortality. The prevalence of children with asthma doubled between 1980 and 1995, from 3.6% in 1980 to 7.5% in 1995. The annual incidence of childhood cancer increased from 1975 until approximately 1990 and seems to have become fairly stable since. Childhood cancer mortality has declined substantially during the past 25 years. Incidence of certain types of cancers has increased since 1974, including acute lymphoblastic leukemia, central nervous system tumors, and non-Hodgkin’s lymphoma. Approximately 6.7% of children aged 5 to 17 were reported to have attention-deficit/hyperactivity disorder in 1997–2000, and approximately 6 of every 1000 children were reported to have received a diagnosis of mental retardation during the same period.

APA, Harvard, Vancouver, ISO, and other styles

47

Sowa, Klaudia, Anna Łobaczuk-Sitnik, Bartosz Piszczatowski, Emilia Duchnowska, Bożena Kosztyła-Hojna, Klaudiusz Nadolny, Jerzy Robert Ładny, and Maciej Zdrojkowski. "SPECIFICS AND DIAGNOSTIC PROCEDURE IN REFLUX-RELATED DYSPHONIA." Wiadomości Lekarskie 73, no. 4 (2020): 814–17. http://dx.doi.org/10.36740/wlek202004137.

Full text

Abstract:

Voice is a work tool for many professional groups. Currently, cases of dysphonia of multiple origin consist a growing issue. Voice disorders may result from disturbed voice production process, congenital defects, post-traumatic conditions, chronic diseases or hormonal disorders. Chronic diseases causing voice disorders include laryngopharyngeal reflux disease and esophageal reflux disease. The chronic character of reflux causes the formation of numerous morphological changes of the larynx, including: hyperemia of the mucosa limited to arytenoid and intraarytenoid area, edema of the vocal folds, edema of the larynx mucosa. These changes contribute to voice disorders. Among the pathological changes of voice organ etiologically associated with reflux, the following disease units may be distinguished: reflux laryngitis, subglottic edema, contact ulceration, larynx granuloma, larynx and pharynx cancer. Many of disorders in the upper respiratory tract are etiologically related to reflux, e.g. dysphonia, grunting, coughing and dyspnoea.

APA, Harvard, Vancouver, ISO, and other styles

48

Travis, Lois B., Chin-Yang Li, Zhi-Nan Zhang, De-Gao Li, Song-Nian Yin, Wong-Ho Chow, Gui-Lan Li, et al. "Hematopoietic Malignancies and Related Disorders Among Benzene-Exposed Workers in China." Leukemia & Lymphoma 14, no. 1-2 (January 1994): 91–102. http://dx.doi.org/10.3109/10428199409049654.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Tustumi, Francisco, Jorge Henrique Bento de Sousa, Nicolas Medeiros Dornelas, Guilherme Maganha Rosa, Milton Steinman, and Edno Tales Bianchi. "The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders." Medical Sciences 9, no. 2 (May 21, 2021): 32. http://dx.doi.org/10.3390/medsci9020032.

Full text

Abstract:

Background: Achalasia and other esophageal dysmotility disorders mimicking achalasia can be associated with cancer. This study aimed to review the main mechanisms for which cancer may develop in esophageal dysmotility disorder patients. Methods: A narrative review was performed. Results: The mechanism for developing squamous cell carcinoma and adenocarcinoma are discussed. Besides, achalasia-like syndromes related to familial KIT-gene mutation and pseudoachalasia are discussed. Conclusions: Knowing the main mechanism for which achalasia can be related to cancer is essential for clinicians to conduct the proper investigation, surveillance, and treatment.

APA, Harvard, Vancouver, ISO, and other styles

50

Sharma, Smita, Rami Abdullah Ali Al Daghreer, and Hamad Aldaghreer. "Cancer Association in Drug Abuse Disorders: A latest Update." South Asian Research Journal of Medical Sciences 4, no. 5 (September 22, 2022): 63–64. http://dx.doi.org/10.36346/sarjms.2022.v04i05.001.

Full text

Abstract:

Drug abuse is the use of drugs in amounts or by methods that is harmful for the health. Drug use disorders (DUD) are associated with a range of adverse health outcomes including increased mortality rates [1, 2]. For example, patients in opioid substitution treatment (OST) are shown to have significantly higher non-drug-related mortality including Cancer than the general population [3, 4]. According to the American Cancer Society, substance abuse and addiction make up about 30% of all cancer deaths. In this review article we tried to summarize that drug abuse disorders are risk factors for Cancers.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!